letrozole has been researched along with Condition, Preneoplastic in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Letrozole proved to be a successful alternative to tamoxifen." | 1.42 | Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance. ( Al-Kharboosh, R; Alamri, A; Axelrod, ML; Bouker, KB; Clarke, R; Dabydeen, SA; Díaz-Cruz, ES; Furth, PA; Hennighausen, L; Kang, K, 2015) |
" Efficacy of vitamin A as a chemopreventive agent for skin cancer could be demonstrated with a dose-response curve after a second-order discriminant analysis was employed." | 1.35 | Knowledge discovery processing and data mining in karyometry. ( Alberts, DS; Bartels, HG; Bartels, PH; Montironi, R; Scarpelli, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dabydeen, SA | 1 |
Kang, K | 1 |
Díaz-Cruz, ES | 1 |
Alamri, A | 1 |
Axelrod, ML | 1 |
Bouker, KB | 1 |
Al-Kharboosh, R | 1 |
Clarke, R | 1 |
Hennighausen, L | 1 |
Furth, PA | 1 |
Bartels, PH | 1 |
Montironi, R | 1 |
Scarpelli, M | 1 |
Bartels, HG | 1 |
Alberts, DS | 1 |
Tekmal, RR | 1 |
Kirma, N | 1 |
Gill, K | 1 |
Fowler, K | 1 |
3 other studies available for letrozole and Condition, Preneoplastic
Article | Year |
---|---|
Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; BRCA1 | 2015 |
Knowledge discovery processing and data mining in karyometry.
Topics: Algorithms; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Papillary; Cell Nucleus; Colonic Neo | 2009 |
Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
Topics: Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors | 1999 |